Table 1.

Env-reactivity of isolated mAbs from pre-vaccine, post-1st, 2nd, and 3rd immunization in basiliximab, anti-Tac, and CH65-treated groups

Treatment group	Animal ID		pre-vaccine	post 1st	post 2nd	post 3rd
basiliximab	6117	mAbs total	59	72	85	20
		Env reactive	12	5	39	3
	6160	mAbs total	24	44	29	63
		Env reactive	0	0	7	23
	6204	mAbs total	36	61	20	31
		Env reactive	0	2	4	1
anti-Tac	6105	mAbs total	33	30	85	62
		Env reactive	6	8	17	19
	6120	mAbs total	0	0	0	0
		Env reactive	0	0	0	0
	6125	mAbs total	48	62	48	35
		Env reactive	2	3	5	22
CH65	6107	mAbs total	6	57	141	10
		Env reactive	0	1	120	0
	6200	mAbs total	12	47	49	63
		Env reactive	0	1	7	29
	6203	mAbs total	23	0	117	66
		Env reactive	0	0	28	16